These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2494716)

  • 1. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy.
    Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z
    Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716
    [No Abstract]   [Full Text] [Related]  

  • 2. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
    Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
    Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
    [No Abstract]   [Full Text] [Related]  

  • 3. Boronated antibodies for neutron capture therapy.
    Abraham R; Müller R; Gabel D
    Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718
    [No Abstract]   [Full Text] [Related]  

  • 4. Boronated compounds for neutron capture therapy.
    Alam F; Bapat BV; Soloway AH; Barth RF; Mafune N; Adams DM
    Strahlenther Onkol; 1989; 165(2-3):121-3. PubMed ID: 2494714
    [No Abstract]   [Full Text] [Related]  

  • 5. Boronophenylalanine for neutron capture therapy of melanoma.
    Coderre JA; Glass JD; Fairchild RG; Micca P; Kalef-Ezra J
    Strahlenther Onkol; 1989; 165(2-3):215-7. PubMed ID: 2494733
    [No Abstract]   [Full Text] [Related]  

  • 6. Plan for synthesis of biomolecules for neutron capture therapy of cervical carcinoma.
    Wongwiechintana C; Choonchartprasert S; Tampitak S; Prachayasittigul S
    Strahlenther Onkol; 1989; 165(2-3):125-6. PubMed ID: 2494715
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological efficacy of a boronated porphyrin as measured in cell culture.
    Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG
    Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728
    [No Abstract]   [Full Text] [Related]  

  • 8. Boron determination for neutron capture therapy by colorimetry and emission spectrometry.
    Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I
    Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723
    [No Abstract]   [Full Text] [Related]  

  • 9. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma.
    Roberto A; Larsson BS
    Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrated approach in the planning of neutron capture therapy.
    Ryabukhin YS
    Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro immunological activity of a dextran-boronated monoclonal antibody.
    Pettersson ML; Courel MN; Girard N; Gabel D; Delpech B
    Strahlenther Onkol; 1989; 165(2-3):151-2. PubMed ID: 2928938
    [No Abstract]   [Full Text] [Related]  

  • 12. Boronated monoclonal antibody 17-1A for potential neutron capture therapy of colorectal cancer.
    Barth RF; Alam F; Soloway AH; Adams DM; Steplewski Z
    Hybridoma; 1986 Jul; 5 Suppl 1():S43-50. PubMed ID: 3744385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First human clinical trial of melanoma neutron capture. Diagnosis and therapy.
    Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T; Obara H; Shirakawa J; Hiratsuka J; Taniyama K
    Strahlenther Onkol; 1989; 165(2-3):251-4. PubMed ID: 2494743
    [No Abstract]   [Full Text] [Related]  

  • 14. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro.
    Ziegler W; Sauerwein W; Streffer C
    Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
    Mill AJ
    Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
    [No Abstract]   [Full Text] [Related]  

  • 16. Method of in situ dosimetry in boron neutron capture therapy.
    Blue J; Roberts W; Blue T; Wang C
    Strahlenther Onkol; 1989; 165(2-3):109-12. PubMed ID: 2494710
    [No Abstract]   [Full Text] [Related]  

  • 17. Fractionation and other clinical considerations in boron neutron capture therapy.
    Durrant KR; Hopewell JW
    Strahlenther Onkol; 1989; 165(2-3):231-3. PubMed ID: 2494739
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutron capture using boronated monoclonal antibody directed against tumor-associated antigens.
    Barth RF; Johnson CW; Wei WZ; Carey WE; Soloway AH; McGuire J
    Cancer Detect Prev; 1982; 5(3):315-23. PubMed ID: 7151064
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose bracketing in boron neutron capture therapy.
    Gahbauer R; Kanellitsas C; Blue T; Wang C; Clendenon N; Fairchild R; Laster B; McGregor J; Goodman J
    Strahlenther Onkol; 1989; 165(2-3):229-30. PubMed ID: 2494738
    [No Abstract]   [Full Text] [Related]  

  • 20. A design study of an accelerator-based epithermal neutron source for boron neutron capture therapy.
    Wang CK; Blue TE; Gahbauer RA
    Strahlenther Onkol; 1989; 165(2-3):75-8. PubMed ID: 2494748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.